- Home
- OCCI vs ACHV Comparison
OCCI vs ACHV Comparison
Compare OCCI & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- ACHV
- Stock Information
- Founded
- OCCI N/A
- ACHV N/A
- Country
- OCCI United States
- ACHV United States
- Employees
- OCCI N/A
- ACHV N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OCCI Finance
- ACHV Health Care
- Exchange
- OCCI Nasdaq
- ACHV Nasdaq
- Market Cap
- OCCI 160.5M
- ACHV 131.3M
- IPO Year
- OCCI N/A
- ACHV N/A
- Fundamental
- Price
- OCCI $6.11
- ACHV $3.08
- Analyst Decision
- OCCI
- ACHV Strong Buy
- Analyst Count
- OCCI 0
- ACHV 2
- Target Price
- OCCI N/A
- ACHV $16.00
- AVG Volume (30 Days)
- OCCI 115.8K
- ACHV 1.6M
- Earning Date
- OCCI 12-11-2023
- ACHV 11-06-2025
- Dividend Yield
- OCCI 24.32%
- ACHV N/A
- EPS Growth
- OCCI N/A
- ACHV N/A
- EPS
- OCCI N/A
- ACHV N/A
- Revenue
- OCCI N/A
- ACHV N/A
- Revenue This Year
- OCCI N/A
- ACHV N/A
- Revenue Next Year
- OCCI $10.19
- ACHV N/A
- P/E Ratio
- OCCI N/A
- ACHV N/A
- Revenue Growth
- OCCI N/A
- ACHV N/A
- 52 Week Low
- OCCI $5.47
- ACHV $1.84
- 52 Week High
- OCCI $10.15
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- OCCI 59.82
- ACHV 56.04
- Support Level
- OCCI $5.84
- ACHV $2.68
- Resistance Level
- OCCI $6.00
- ACHV $3.30
- Average True Range (ATR)
- OCCI 0.11
- ACHV 0.25
- MACD
- OCCI 0.03
- ACHV 0.02
- Stochastic Oscillator
- OCCI 92.88
- ACHV 49.38
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.